Subscribe to Search results
Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission.
Published on:
Cutter conducted experiments with heat treatment which showed Factor 9 activity could be preserved.
Published on:
Hyland experimented with dry heat approach.
Published on:
FDA licensed Hyland's dry heat-treated product.
Published on:
FDA licensed Armour's heat-treated product, followed by Alpha's and Cutter's products in February 1984.
Published on: